Should vancomycin use in dialysis patients be restricted?

Seminars in Dialysis

Volumn 9, Issue 3, 1996, Pages 235-237

  Strausbaugh, Larry J ^a,b   Bennett, William M ^b  

^a PORTLAND VA MEDICAL CENTER   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0011146723     PISSN: 08940959     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1525-139x.1996.tb00659.x     Document Type: Article

References (16)

1. Centers for Disease Control and Prevention: Recommendations for preventing the spread of vancomycin resistance: Recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC). MMWR 44(No. RR-12):1-13, 1995
2. Spera RV Jr., Farber BF: Multidrug-resistant Enterococcus faecium - an untreatable nosocomial pathogen. Drugs 48:678-688, 1994
3. Spera RV Jr., Farber BF: Multiply-resistant Enterococcus faecium - the nosocomial pathogen of the 1990s. JAMA 268:2563-2564, 1992
4. Murray BE: The life and times of the enterococcus. Clin Microbiol Rev 3:46-65, 1990
5. Chenoweth C, Schaberg D: The epidemiology of enterococci. Eur J Clin Microbiol Infect Dis 9:80-39, 1990
6. Schaberg DR, Culver DH, Gaynes RP: Major trends in the microbial etiology of nosocomial infections. Am J Med 91(suppl 3B):3B72S-3B75S, 1991
7. Patterson JE, Zervos MJ: High-level gentamicin resistance in Enterococcus: microbiology, genetic basis, and epidemiology. J Infect Dis 12:644-651, 1990
8. Centers for Disease Control and Prevention: Nosocomial enterococci resistant to vancomycin - United States, 1989-1993. MMWR 42:597-599, 1993
9. Handwerger S, Raucher B, Altarac D, Monka J, Marchione S, Singh KV, Murray BE, Wolff J, Walters B: Nosocomial outbreak due to Enterococcus faecium highly resistant to vancomycin, penicillin, and gentamicin. J Infect Dis 16:750-755, 1993
10. Morris JG Jr., Shay DK, Hebden JN, McCarter RJ Jr., Perdue BE, Jarvis W, Johnson JA, Dowling TC, Polish LB, Schwalbe RS: Enterococci resistant to multiple antimicrobial agents, including vancomycin - establishment of endemicity in a university medical center. Ann Intern Med 123:250-259, 1995
11. Livornese LL, Dias S, Samel C, Romanowski B, Taylor S, May P, Pitsakis P, Woods G, Kaye D, Levison ME, Johnson CC: Hospital-acquired infection with vancomycin-resistant Enterococcus faecium transmitted by electronic thermometers. Ann Intern Med 117:112-116, 1992
12. Boyce JM, Opal SM, Chow JW, Zervos MJ, Potter-Bynoe G, Sherman CB, Romulo RLC, Fortna S, Medeiros A: Outbreak of multidrug-resistant Enterococcus faecium with transferable vanB class vancomycin resistance. J Clin Microbiol 32:1148-1153, 1994
13. Frieden TR, Munsiff SS, Low DE, Willey BM, Williams G, Faur Y, Eisner W, Warren S, Kreiswirth B: Emergence of vancomycin-resistant enterococci in New York City. Lancet 342:76-79, 1993
14. Lam TY, Vas SI, Oreopoulos DG: Long-term intraperitoneal vancomycin in the prevention of recurrent peritonitis during CAPD: Preliminary results. Perit Dial Int 11:281-282, 1991
15. Kaplan AH, Gilligan PH, Facklam RR: Recovery of resistant enterococci during vancomycin prophylaxis. J Clin Microbiol 26:1216-1218, 1988
16. Nicas TI, Mullen DL, Flokowitsch JE, Preston DA, Snyder NJ, Stratford RE, Cooper RD: Activities of the semisynthetic glycopeptide LY191145 against vancomycin-resistant enterococci and other gram-positive bacteria. Antimicrob Agents Chemother 39:2585-2587, 1995